138 related articles for article (PubMed ID: 32962431)
1. S100A9/CD163 Expression in Circulating Classical Monocytes in Chronic Obstructive Pulmonary Disease.
Yamashita M; Utsumi Y; Yamauchi K
COPD; 2020 Oct; 17(5):587-594. PubMed ID: 32962431
[TBL] [Abstract][Full Text] [Related]
2. S100A9/CD163 expression profiles in classical monocytes as biomarkers to discriminate idiopathic pulmonary fibrosis from idiopathic nonspecific interstitial pneumonia.
Yamashita M; Utsumi Y; Nagashima H; Nitanai H; Yamauchi K
Sci Rep; 2021 Jun; 11(1):12135. PubMed ID: 34108546
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of CD163, CD204 and CD206 on alveolar macrophages in the lungs of patients with severe chronic obstructive pulmonary disease.
Kaku Y; Imaoka H; Morimatsu Y; Komohara Y; Ohnishi K; Oda H; Takenaka S; Matsuoka M; Kawayama T; Takeya M; Hoshino T
PLoS One; 2014; 9(1):e87400. PubMed ID: 24498098
[TBL] [Abstract][Full Text] [Related]
4. Expression of CD163 and HLA-DR molecules on the monocytes in chronic lymphocytic leukemia patients.
Kowalska W
Folia Histochem Cytobiol; 2020; 58(1):17-24. PubMed ID: 32176313
[TBL] [Abstract][Full Text] [Related]
5. Differential expression and predictive value of monocyte scavenger receptor CD163 in populations with different tuberculosis infection statuses.
Liu Q; Ou Q; Chen H; Gao Y; Liu Y; Xu Y; Ruan Q; Zhang W; Shao L
BMC Infect Dis; 2019 Nov; 19(1):1006. PubMed ID: 31779590
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of the CD163-Haptoglobin Axis in the Airways of COPD Patients.
Higham A; Baker JM; Jackson N; Shah R; Lea S; Singh D
Cells; 2021 Dec; 11(1):. PubMed ID: 35011566
[TBL] [Abstract][Full Text] [Related]
7. CD14+CD16+ and CD14+CD163+ monocyte subpopulations in kidney allograft transplantation.
Sekerkova A; Krepsova E; Brabcova E; Slatinska J; Viklicky O; Lanska V; Striz I
BMC Immunol; 2014 Feb; 15():4. PubMed ID: 24499053
[TBL] [Abstract][Full Text] [Related]
8. [Expression of toll-like receptors on CD14+ monocytes from patients with chronic obstructive pulmonary disease and smokers].
Pan MM; Sun TY; Zhang HS
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2103-7. PubMed ID: 19080469
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD206 and CD163 on intermediate CD14
Li X; Du N; Xu G; Zhang P; Dang R; Jiang Y; Zhang K
Virus Res; 2018 Jul; 253():92-102. PubMed ID: 29857122
[TBL] [Abstract][Full Text] [Related]
10. CD163 levels, pro- and anti-inflammatory cytokine secretion of monocytes in children with pulmonary tuberculosis.
Aktas Cetin E; Pur Ozyigit L; Gelmez YM; Cakir E; Gedik AH; Deniz G
Pediatr Pulmonol; 2017 May; 52(5):675-683. PubMed ID: 27685837
[TBL] [Abstract][Full Text] [Related]
11. The expansion of CD14+ CD163+ subpopulation of monocytes and myeloid cells-associated cytokine imbalance; candidate diagnostic biomarkers for celiac disease (CD).
Babania O; Mohammadi S; Yaghoubi E; Sohrabi A; Sadat Seyedhosseini F; Abdolahi N; Yazdani Y
J Clin Lab Anal; 2021 Oct; 35(10):e23984. PubMed ID: 34449925
[TBL] [Abstract][Full Text] [Related]
12. Circulating classical CD14++CD16- monocytes predict shorter time to initial treatment in chronic lymphocytic leukemia patients: Differential effects of immune chemotherapy on monocyte-related membrane and soluble forms of CD163.
Lapuc I; Bolkun L; Eljaszewicz A; Rusak M; Luksza E; Singh P; Miklasz P; Piszcz J; Ptaszynska-Kopczynska K; Jasiewicz M; Kaminski K; Dabrowska M; Bodzenta-Lukaszyk A; Kloczko J; Moniuszko M
Oncol Rep; 2015 Sep; 34(3):1269-78. PubMed ID: 26135617
[TBL] [Abstract][Full Text] [Related]
13. Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD.
Kunz LI; Lapperre TS; Snoeck-Stroband JB; Budulac SE; Timens W; van Wijngaarden S; Schrumpf JA; Rabe KF; Postma DS; Sterk PJ; Hiemstra PS;
Respir Res; 2011 Mar; 12(1):34. PubMed ID: 21426578
[TBL] [Abstract][Full Text] [Related]
14. Effects of corticosteroids on COPD lung macrophage phenotype and function.
Higham A; Scott T; Li J; Gaskell R; Dikwa AB; Shah R; Montero-Fernandez MA; Lea S; Singh D
Clin Sci (Lond); 2020 Apr; 134(7):751-763. PubMed ID: 32227160
[TBL] [Abstract][Full Text] [Related]
15. CD163 as a Potential Biomarker of Monocyte Activation in Ischemic Stroke Patients.
Greco R; Demartini C; Zanaboni AM; Tumelero E; Persico A; Candeloro E; Morotti A; Amantea D; Tassorelli C
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201498
[TBL] [Abstract][Full Text] [Related]
16. CD163 positive subsets of blood dendritic cells: the scavenging macrophage receptors CD163 and CD91 are coexpressed on human dendritic cells and monocytes.
Maniecki MB; Møller HJ; Moestrup SK; Møller BK
Immunobiology; 2006; 211(6-8):407-17. PubMed ID: 16920480
[TBL] [Abstract][Full Text] [Related]
17. Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma.
Jones K; Vari F; Keane C; Crooks P; Nourse JP; Seymour LA; Gottlieb D; Ritchie D; Gill D; Gandhi MK
Clin Cancer Res; 2013 Feb; 19(3):731-42. PubMed ID: 23224400
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of CD163 on monocyte subsets in healthy and HIV-1 infected individuals.
Tippett E; Cheng WJ; Westhorpe C; Cameron PU; Brew BJ; Lewin SR; Jaworowski A; Crowe SM
PLoS One; 2011; 6(5):e19968. PubMed ID: 21625498
[TBL] [Abstract][Full Text] [Related]
19. Identification of a distinct glucocorticosteroid-insensitive pulmonary macrophage phenotype in patients with chronic obstructive pulmonary disease.
Chana KK; Fenwick PS; Nicholson AG; Barnes PJ; Donnelly LE
J Allergy Clin Immunol; 2014 Jan; 133(1):207-16.e1-11. PubMed ID: 24176116
[TBL] [Abstract][Full Text] [Related]
20. Soluble CD163, a specific macrophage activation marker, is decreased by anti-TNF-α antibody treatment in active inflammatory bowel disease.
Dige A; Støy S; Thomsen KL; Hvas CL; Agnholt J; Dahlerup JF; Møller HJ; Grønbaek H
Scand J Immunol; 2014 Dec; 80(6):417-23. PubMed ID: 25346048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
